Anemia and heart failure a new pathway?
Francis
Gary S
GS
Kanderian
Anne
A
D018798:Anemia, Iron-Deficiency / Q000188:drug therapy* / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D004921:Erythropoietin / Q000627:therapeutic use; D005290:Ferric Compounds / Q000008:administration & dosage*; D000077605:Ferric Oxide, Saccharated; D005937:Glucaric Acid; D006333:Heart Failure / Q000150:complications* / Q000378:metabolism; D006397:Hematinics / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D020097:Natriuretic Peptide, Brain / Q000187:drug effects / Q000378:metabolism; D010446:Peptide Fragments / Q000187:drug effects / Q000378:metabolism; D016896:Treatment Outcome
D005290:Ferric Compounds; D006397:Hematinics; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D004921:Erythropoietin; D020097:Natriuretic Peptide, Brain; D000077605:Ferric Oxide, Saccharated; D005937:Glucaric Acid